期刊文献+

Toll样受体9在食管鳞癌细胞的表达及作用 被引量:2

The expression and roles of TLR9 in esophageal cancer cell
下载PDF
导出
摘要 目的观察Toll样受体9(TLR9)在食管鳞癌细胞的表达及作用。方法用RT-PCR方法检测食管鳞癌细胞系TE10、TE30和TE70上TLR9的表达;流式细胞术检测TE10细胞上TLR9的表达;用TLR9的激动剂CpG寡脱氧核苷酸(CpG ODN)10μg/ml分别作用TE10细胞12 h、24 h和48 h后,用MTT法检测细胞生长抑制率。结果 TE10细胞上有TLR9的表达;TLR 9激动剂CpG ODN作用于TE10细胞后不同时间均能明显促进TE10细胞生长(P<0.01)。结论 TLR9激动剂CpG ODN可促进食管鳞癌细胞的增殖,提示TLR9可能是食管鳞癌治疗的靶点之一。 Objective To investigate the expression and possible mechanism of TLR9 in the incidence of human esophageal squa- mous cell carcinoma cells. Methods The expression of TLR9 in esophageal squamous cell carcinoma cell lines TE10, TE30 and TE70 cells was measured by RT-PCR and the expression of TLR9 in TE10 was detected by flow cytometry as well. The inhibitive effect of 10 μg/ml TLR9 agonist ( CpG ODN) in TE10 cells at 24 h, 48 h and 72 h was observed by MTr assay. Results TLR9 was expressed in TE10 cells. TLR9 agonist CpG ODN promoted the growth of TE10 cells (P 〈 0, 01 ) at different time point. Conclusions TLR9 agonist CpG ODN could promote the proliferation of esophageal carcinoma cells indicating that TLR9 may be one of the targets of squamous cell carcinoma treatment.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2013年第8期1818-1819,共2页 Chinese Journal of Gerontology
基金 国家自然科学基金(No.31260243 30860320) 宁夏自然科学基金(No.NZ11100) 宁夏医科大学"博士学位建设学科"开放课题(No.KF2010-39) 宁夏高校科学研究项目(宁教高〔2010〕297号)
关键词 CPG-ODN 四甲基偶氮唑盐 食管鳞癌细胞 TOLL样受体9 CpG ODN MTY Esophageal cancer cells TLR9
  • 相关文献

参考文献5

二级参考文献11

  • 1张思维,雷正龙,李光琳,邹小农,陈万青,赵平.中国肿瘤登记地区2005年发病死亡资料分析[J].中国肿瘤,2009,18(12):973-979. 被引量:32
  • 2Zeromski J, Mozer - Lisewska I, Kaczmarek M. Significance of Toll - like Receptors Expression in Tumor Growth and Spreading: A Short Review[J]. Cancer Microenviron,2008,1 ( 1 ) :37 - 42.
  • 3Ren T, Xu L, Jiao S, et al. TLR9 signaling promotes tumor progression of human lung cancer cell in vivo [ J ]. Pathol Oncol Res, 2009,15 (4) : 623 - 630.
  • 4Vaisanen MR, Vaisanen T, Jukkola - Vuorinen A, et al. Expression of toll - like receptor - 9 is increased in poorly differentiated prostate tumors [ J ]. Prostate, 2010, 70(8) :817 -824.
  • 5Chuang CM, Monie A, Wu A, et al. Treatment with LL -37 Peptide Enhances Antitumor Effects Induced by CpG Oligodeoxynucleotides Against Ovarian Cancer[ J ]. Hum Gene Ther,2009,20(4) :303 -313.
  • 6Droemann D, Albrecht D, Gerdes J, et al. Human lung cancer cells express functionally active Toll - like receptor 9 [ J ]. Respir Res,2005,6 ( 1 ) : 1 - 10.
  • 7Kortylewski M, Kujawski M, Herrmann A, et al. Toll - like receptor 9 activation of signal transducer and activator of transcription 3 constrains its agonist - based immunotherapy[ J]. Cancer Res, 2009, 69(6) :2497 - 2505.
  • 8Schmausser B,Andrulis M,Endrich S,Muller-Hermelink HK,Eck M:Toll-like receptors TLR4,TLR5 and TLR9 on gastric carcinoma cells:an implication for interaction with helicobacter pylori[J].Int J Med Microbiol,2005,295:179-185.
  • 9Holtick U,Scheulen ME,von Bergwelt-Baildon MS,et al.Toll-like receptor 9 agonists as cancer therapeutics[J].Expert Opin Investig Drugs,2011,20(3):361-372.
  • 10于吉人.胃癌新辅助化疗的研究进展[J].实用肿瘤杂志,2010,25(5):594-596. 被引量:6

共引文献3

同被引文献5

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部